Jacob Gorman, Ph.D. - Publications

2014 Immunology University of Iowa, Iowa City, IA 
Immunology, Cell Biology, Oncology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Liu Y, Pagacz J, Wolfgeher DJ, Bromerg KD, Gorman JV, Kron SJ. Senescent cancer cell vaccines induce cytotoxic T cell responses targeting primary tumors and disseminated tumor cells. Journal For Immunotherapy of Cancer. 11. PMID 36792123 DOI: 10.1136/jitc-2022-005862  0.377
2021 Chen JL, Barr JY, Zuk JJ, Gorman JV, Colgan JD. Reciprocal SH2-SH3 Domain Contacts between ITK Molecules Limit T Cell Receptor Signaling in Th2-type CD4 T Cells. Immunological Investigations. 1-18. PMID 34844506 DOI: 10.1080/08820139.2021.2007262  0.684
2018 Gorman JV, Colgan JD. Acute Stimulation Generates Tim-3-expressing Th1-type CD4 T Cells That Persist In Vivo and Show Enhanced Effector Function. Immunology. PMID 29315553 DOI: 10.1111/Imm.12890  0.71
2015 Phong BL, Avery L, Sumpter TL, Gorman JV, Watkins SC, Colgan JD, Kane LP. Tim-3 enhances FcεRI-proximal signaling to modulate mast cell activation. The Journal of Experimental Medicine. PMID 26598760 DOI: 10.1084/Jem.20150388  0.694
2015 Thakar NY, Ovchinnikov DA, Hastie ML, Kobe B, Gorman JJ, Wolvetang EJ. TRAF2 recruitment via T61 in CD30 drives NFκB activation and enhances hESC survival and proliferation. Molecular Biology of the Cell. 26: 993-1006. PMID 25568342 DOI: 10.1091/mbc.E14-08-1290  0.426
2014 Gorman JV, Colgan JD. Response to Comment on "Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infection". Journal of Immunology (Baltimore, Md. : 1950). 193: 467-8. PMID 24994908 DOI: 10.4049/Jimmunol.1401297  0.713
2014 Gorman JV, Colgan JD. Regulation of T cell responses by the receptor molecule Tim-3. Immunologic Research. 59: 56-65. PMID 24825777 DOI: 10.1007/S12026-014-8524-1  0.718
2014 Gorman JV, Starbeck-Miller G, Pham NL, Traver GL, Rothman PB, Harty JT, Colgan JD. Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infection. Journal of Immunology (Baltimore, Md. : 1950). 192: 3133-42. PMID 24567532 DOI: 10.4049/Jimmunol.1302290  0.722
2012 Chiba S, Baghdadi M, Akiba H, Yoshiyama H, Kinoshita I, Dosaka-Akita H, Fujioka Y, Ohba Y, Gorman JV, Colgan JD, Hirashima M, Uede T, Takaoka A, Yagita H, Jinushi M. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nature Immunology. 13: 832-42. PMID 22842346 DOI: 10.1038/Ni.2376  0.569
2012 Curtiss ML, Gorman JV, Businga TR, Traver G, Singh M, Meyerholz DK, Kline JN, Murphy AJ, Valenzuela DM, Colgan JD, Rothman PB, Cassel SL. Tim-1 regulates Th2 responses in an airway hypersensitivity model. European Journal of Immunology. 42: 651-61. PMID 22144095 DOI: 10.1002/Eji.201141581  0.712
Show low-probability matches.